このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

Keeping Current CMEの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Are you making the most of immune checkpoint inhibitors in advanced gynecologic cancers? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-practice-optimizing-immunotherapy-recurrent-2026a1000zys?…
Experts discuss the latest efficacy and safety data on systemic treatments for prurigo nodularis. Credit available for this activity expires: 10/12/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/itch-insight-prurigo-nodularis-countdown-2026a10010t5…
Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA). Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pathway-prescription-alopecia-areata…
Where do oral obesity medications fit alongside injectables, and how can you match the right option to the right patient? Credit available for this activity expires: 10/09/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-injectables-where-do-ora…
Experts discuss recent clinical guidelines and trial data on JAK inhibitors for systemic lupus erythematosus (SLE) treatment. Credit available for this activity expires: 10/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/next-frontier-sle-management…
免責: このページに埋め込まれているポッドキャストとアートワークは Medscape からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。